Download Full Text (2.8 MB)

Document Type



The purpose of this research and literature review is to compare the efficacy of the implantable pulmonary artery pressure monitoring device, CardioMEMS, to traditional heart failure management in terms of reducing hospital readmissions. The data bases of Cochrane Library, PubMed, Clinical Key, and DynaMed Plus were utilized. Because the CardioMEMS device is relatively novel in the treatment of heart failure, the time frame of search results was expanded to 10 years to include research from the original clinical trials. A total of 17 peer reviewed works were chosen for this review which included meta-analyses, systematic reviews, randomized controlled trials, and longitudinal studies. Current literature indicates that the CardioMEMS device promotes earlier detection of worsening congestive heart failure than traditional management methods. Earlier detection of increasing pulmonary artery pressures allows for earlier corrective interventions, making CardioMEMS more effective in reducing heart failure related readmissions. The data also indicates that the device is cost-effective as well. However, CardioMEMS may not be appropriate or cost effective for patients with end stage heart failure or limited life expectancy. Additional studies are currently underway to examine the efficacy of the CardioMEMS device in a broader range of patients as it is currently only FDA approved for New York Heart Association class III heart failure patients


Physician Assistant Studies

Date of Work


Publication Date



Heart Failure, CardioMEMS, implantable pulmonary artery pressure monitoring device, Peripheral edema, dyspnea


Medicine and Health Sciences

Comparison of Traditional Management of Heart Failure with CardioMEMS